Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;30(18):1386-1397.
doi: 10.2174/0113816128291321240329050945.

Colorectal Cancer Stem Cell Biomarkers: Biological Traits and Prognostic Insights

Atena Soleimani  1 , Nikoo Saeedi  2 , Abdulridha Mohammed Al-Asady  3 , Elnaz Nazari  4 , Reyhane Hanaie  5 , Majid Khazaei  4 , Elnaz Ghorbani  6 , Hamed Akbarzade  1 , Mikhail Ryzhikov  7 , Amir Avan  8 , Seyed Mahdi Hasanian Mehr  1
Affiliations
Review

Colorectal Cancer Stem Cell Biomarkers: Biological Traits and Prognostic Insights

Atena Soleimani et al. Curr Pharm Des. 2024.

Abstract

Due to self-renewal, differentiation, and limitless proliferation properties, Cancer Stem Cells (CSCs) increase the probability of tumor development. These cells are identified by using CSC markers, which are highly expressed proteins on the cell surface of CSCs. Recently, the therapeutic application of CSCs as novel biomarkers improved both the prognosis and diagnosis outcome of colorectal Cancer. In the present review, we focused on a specific panel of colorectal CSC markers, including LGR5, ALDH, CD166, CD133, and CD44, which offers a targeted and comprehensive analysis of their functions. The selection criteria for these markers cancer were based on their established significance in Colorectal Cancer (CRC) pathogenesis and clinical outcomes, providing novel insights into the CSC biology of CRC. Through this approach, we aim to elevate understanding and stimulate further research for developing effective diagnostic and therapeutic strategies in CRC.

Keywords: ALDH; CD133; CD166; CD44; LGR5; cancer stem cell; colon cancer..

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Siegel R.L.; Wagle N.S.; Cercek A.; Smith R.A.; Jemal A.; Colorectal cancer statistics, 2023. CA Cancer J Clin 2023,73(3),233-254 - DOI - PubMed
    1. Siegel R.L.; Miller K.D.; Fuchs H.E.; Jemal A.; Cancer statistics, 2022. CA Cancer J Clin 2022,72(1),7-33 - DOI - PubMed
    1. Morgan E.; Arnold M.; Gini A.; Lorenzoni V.; Cabasag C.J.; Laversanne M.; Vignat J.; Ferlay J.; Murphy N.; Bray F.; Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN. Gut 2023,72(2),338-344 - DOI - PubMed
    1. Xi Y.; Xu P.; Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 2021,14(10),101174 - DOI - PubMed
    1. Arnold M.; Sierra M.S.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017,66(4),683-691 - DOI - PubMed

Substances